As a post-transcriptional regulatory element, NR2C2-uORF inhibited NR2C2 expression from a bypass through inhibiting NR2C2 mRNA expression thereby significantly inhibited the malignant behaviors of glioma cells. This evidence concerns the gene NR2C2 and central nervous system cancer.